I am a Principal Investigator and Senior Research Fellow at the University of Auckland, and an Associate Investigator at the Maurice Wilkins Centre, a Centre of Research Excellence. As a medicinal chemist working at the interface of synthetic chemistry, cancer biology, and translational medicine, I lead a research programme focused on the development of next-generation targeted therapeutics. My work includes the design of antibody-drug conjugates (ADCs), radionuclide-antibody conjugates (RACs), and site-selective strategies for peptide and protein functionalisation to enable precision cancer therapy and molecular imaging. I currently hold a Sir Charles Hercus Research Fellowship from the Health Research Council of New Zealand, through which I lead a multidisciplinary initiative to develop multi-payload ADCs tailored to overcome therapeutic resistance in ovarian cancer. My research has contributed to the advancement of linker technologies, payload integration, and tumour-selective delivery strategies with strong translational potential.